Disorder of Tendon of Biceps Clinical Trial
Official title:
Analysis of the Fixation of the Proximal Long Head of the Biceps Tendon
NCT number | NCT01317771 |
Other study ID # | RC-5202 |
Secondary ID | |
Status | Withdrawn |
Phase | |
First received | |
Last updated | |
Start date | March 11, 2011 |
Est. completion date | March 1, 2013 |
Verified date | August 2020 |
Source | West Penn Allegheny Health System |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Ten randomly selected patients that have undergone an open proximal biceps tendon tenodesis with an EndoButton for bicipital pathology with Christopher Schmidt, MD, will be asked to participate in the study. The study will assess the tendon healing to bone through magnetic resonance imaging (MRI). Individuals will also be asked to fill a visual analog scale (VAS) pain and disability of the arm shoulder and hand (DASH) assessment tools. The variables for our objective will include age, hand dominance, gender and chronicity of symptoms prior to surgery, and other related surgical procedures.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | March 1, 2013 |
Est. primary completion date | March 1, 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Undergone open subpectoral proximal biceps tenodesis with the EndoButton Exclusion Criteria: - No history of surgery or disability in the contra-lateral extremity - Not a member of a legally restricted group or protected population - No prior surgery or further surgery on the extremity of interest - No condition preventing the individual from undergoing a MRI |
Country | Name | City | State |
---|---|---|---|
United States | Allegheny Imaging of McCandless | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
West Penn Allegheny Health System |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01538459 -
Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene Block
|
Phase 3 |